✦ LIBER ✦

A phase I trial of oxaliplatin and topotecan in recurrent ovarian carcinoma

✍ Scribed by John C. Elkas; William E. Winter III; Mildred R. Chernofsky; Jan Sunde; Michael A. Bidus; Sarah Bernstein; G. Scott Rose

Book ID: 113960786
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 127 KB
Volume: 104
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2006.08.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I-II trial of weekly topotecan i

A phase I-II trial of weekly topotecan in the treatment of recurrent cervical carcinoma

✍ Larry E. Puls; Bunny Phillips; Chris Schammel; James E. Hunter; David Griffin 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 179 KB

A prospective randomized trial of thalid

A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma

✍ Levi S. Downs Jr.; Patricia L. Judson; Peter A. Argenta; Rahel Ghebre; Melissa A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## BACKGROUND. Thalidomide is an antiangiogenic agent with immune modulating potential. The objective of this study was to determine response rates among women who were treated for recurrent ovarian cancer using topotecan with or without thalidomide. ## METHODS. Women were enrolled i

A phase I/II trial of weekly topotecan a

A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma

✍ Peter G. Rose; Mary Smrekar; Pamela Haba; Christina Visser; John F. Beeler 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A Phase I/II Study of Topotecan in Combi

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

✍ Giorgio Bolis; Giovanna Scarfone; Cesarina Sciatta; Gian Piero Polverino; Cristi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

A Phase I Study of Weekly Topotecan and

A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

✍ H. Homesley; B. Benigno; J. Williams; L. Vaccarello 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Sequential topotecan and oral etoposide

Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane : Results from a multicenter Phase I/II study

✍ Bo Gronlund; Svend A. Engelholm; György Horvath; Johanna Mäenpää; Mona Ridderhei 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## BACKGROUND The objectives of this study were to determine the maximum tolerable dose (MTD), toxicity, efficacy, and feasibility of a sequential regimen of fixed‐dose topotecan (1.00 mg/m^2^ on Days 1–5) and increasing doses of oral etoposide (50 mg, 75 mg, and 100 mg on Days 6–12 or